<!doctype html>
<style>
@charset "utf-8";
body {
	height: 100%;
	margin: 0;
	padding: 0;
}

.banner {
	position: fixed;
	top: 0;
	width: 100%;
	height: 65px;
	background: gray;
	line-height: 65px;
}
.spacer {
	height: 10px;
}

.main-content {
	padding: 5%;
}

.collapse_ACT {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-style: none solid none none;
	border-color: #B4045F;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_ACT + input{
	display: none;
}
.collapse_ACT + input + div{
	display: none;
}
.collapse_ACT + input:checked + div{
	display: block;
}
.ACT {
	text-align: justify;
	text-justify: inter-word;
}
.ACT_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #B4045F;
}
.ACT_collapse_similarity:hover{
	background: #e5d3dc;
}
.ACT_collapse_similarity + input {
	display: none;
}
.ACT_collapse_similarity + input + div{
	display: none;
}

.ACT_collapse_similarity + input:checked + div{
	display: block;
}
.ACT_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.ACT_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #B4045F;
	padding-left: 5px;
}
.ACT_collapse_similarity:hover{
	background: #e5d3dc;
}
.ACT_collapse_similarity + input {
	display: none;
}
.ACT_collapse_similarity + input + div{
	display: none;
}
.ACT_collapse_similarity + input:checked + div{
	display: block;
}
.ACT_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.ACT_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #B4045F;
}
.ACT_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_DOM {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-style: none solid none none;
	border-color: #B404AE;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_DOM + input{
	display: none;
}
.collapse_DOM + input + div{
	display: none;
}
.collapse_DOM + input:checked + div{
	display: block;
}
.DOM {
	text-align: justify;
	text-justify: inter-word;
}
.DOM_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #B404AE;
	padding-left: 5px;
}
.DOM_collapse_similarity:hover{
	background: #e8d7e7;
}
.DOM_collapse_similarity + input {
	display: none;
}
.DOM_collapse_similarity + input + div{
	display: none;
}
.DOM_collapse_similarity + input:checked + div{
	display: block;
}
.DOM_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}.DOM_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #B404AE;
}
.DOM_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_EVO {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #7401DF;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_EVO + input{
	display: none;
}
.collapse_EVO + input + div{
	display: none;
}
.collapse_EVO + input:checked + div{
	display: block;
}
.EVO {
	text-align: justify;
	text-justify: inter-word;
}
.EVO_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #7401DF;
	padding-left: 5px;
}
.EVO_collapse_similarity:hover{
	background: #e2d7ed;
}
.EVO_collapse_similarity + input {
	display: none;
}
.EVO_collapse_similarity + input + div{
	display: none;
}
.EVO_collapse_similarity + input:checked + div{
	display: block;
}
.EVO_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.EVO_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #7401DF;
}
.EVO_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_RP {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #0174DF;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_RP + input{
	display: none;
}
.collapse_RP + input + div{
	display: none;
}
.collapse_RP + input:checked + div{
	display: block;
}
.RP {
	text-align: justify;
	text-justify: inter-word;
}
.RP_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #0174DF;
	padding-left: 5px;
}
.RP_collapse_similarity:hover{
	background: #c9d7e2;
}
.RP_collapse_similarity + input {
	display: none;
}
.RP_collapse_similarity + input + div{
	display: none;
}
.RP_collapse_similarity + input:checked + div{
	display: block;
}
.RP_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.RP_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #0174DF;
}
.RP_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_SIT {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #0489B1;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_SIT + input{
	display: none;
}
.collapse_SIT + input + div{
	display: none;
}
.collapse_SIT + input:checked + div{
	display: block;
}
.SIT {
	text-align: justify;
	text-justify: inter-word;
}
.SIT_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #0489B1;
	padding-left: 5px;
}
.SIT_collapse_similarity:hover{
	background: #d0dfe2;
}
.SIT_collapse_similarity + input {
	display: none;
}
.SIT_collapse_similarity + input + div{
	display: none;
}
.SIT_collapse_similarity + input:checked + div{
	display: block;
}
.SIT_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.SIT_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #0489B1;
}
.SIT_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_TU {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #04B486;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_TU + input{
	display: none;
}
.collapse_TU + input + div{
	display: none;
}
.collapse_TU + input:checked + div{
	display: block;
}
.TU {
	text-align: justify;
	text-justify: inter-word;
}
.TU_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #04B486;
	padding-left: 5px;
}
.TU_collapse_similarity:hover{
	background: #d0e2de;
}
.TU_collapse_similarity + input {
	display: none;
}
.TU_collapse_similarity + input + div{
	display: none;
}
.TU_collapse_similarity + input:checked + div{
	display: block;
}
.TU_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.TU_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #04B486;
}
.TU_similar > a {
	text-decoration: none;
	color: gray;
}

ul { 
	list-style-type: none;
	padding: 0;
	margin: 0;
}
ul li > a {
	text-decoration: none;
	color: gray;
}
ul li:hover, ul li:focus {
	background: #F0F0F0;
}

ul li:first-child span {
  border-left:none;  
}

</style>
<html>
<head>
<meta charset="utf-8">
<title>TF properties - FeaR</title>
<meta name="theme-color" content="#ffffff">
</head>
<body>
	<div class="banner">
		<center><font color="white" size="16px" face="arial">FeaR</font></center>
	</div>
	<div align="center" class="main-content">
		<div class="spacer">
	</div><br>			<label class="collapse_ACT" for="_1"><font size="5px">FeaR transcriptional activity</font></label>
				<input id="_1" type="checkbox">
				<div class="ACT"><br><ul><li>The sequence accession numbers are : FeaR , EMBUGenBank X99402 ; XylS , SWISS-PROT P07859 ; RhaR , SWISS-PROT P09378 ; RhaS , SWISS-PROT P09377 ; AraC , SWISS-PROT P03021 ; MelR , SWISS-PROT P10411 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9043126" target="_blank">9043126</a>]<br></li>
<li>These results suggest that the aldehyde is the direct inducer for the PEA cata-bolic pathway and is the likely coeffector of FeaR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>Finely Tuned Regulation of the Aromatic Amine Degradation Pathway in Escherichia coli Ji Zeng , Stephen Spiro Department of Molecular and Cell Biology , The University of Texas at Dallas , Richardson , Texas , USA FeaR is an AraC family regulator that activates transcription of the tynA and feaB genes in Escherichia coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>The FeaR protein is represented by open circles , CRP-cAMP by ﬁlled circles , and NAC by squares .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>These DNA fragments were ﬂuorescently labeled and used in measurements of ﬂuorescence anisotropy in the presence of increasing concentrations of the FeaR CTD ( 28 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>In any case , the simplest explanation for our results is that 3-nitrotyramine , or a molecule related to 3-nitrotyramine ( perhaps 4-hydroxy-3-nitro-phenylacetaldehyde ) , can function with FeaR to control-the-activity of the tynA and feaB promoters .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=18658270" target="_blank">18658270</a>]<br></li>
<li>We show that the expression of feaR is regulated by carbon or nitrogen limitation and is not subject to autoregulation by the FeaR protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>During growth on nonpreferred carbon or nitrogen sources ( glycerol medium and glutamine medium ) , feaR expression is elevated 2 - to 6-fold , but there is no activation of tynA or feaB in the absence of the FeaR coactivator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>Overall , we ﬁnd that tynA expression is activated in both carbon - and nitrogen-limited cells in the presence of a FeaR coactivator , while feaB can be activated only during carbon limitation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>During carbon limitation in the presence of the FeaR coactivators ( glycerol me-dium plus tyramine/PEA ) , both tynA and feaB are upregulated .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>However , during nitrogen limitation in the presence of the FeaR coactivators ( glutamine medium plus tyramine ) , only tynA is upregulated , while feaB expression remains at a basal level .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>This increase in feaR expression is not sufﬁcient to activate expression of tynA and feaB unless a pathway inducer is also present ( although a nonphysiological increase in FeaR abundance may lead to induction of its targets in the absence of inducer [ see Fig .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>Thus , while tynA and feaB are coordinately regulated by FeaR , their expression is also ﬁne-tuned by other regulators ( CRP and NAC ) and by the regulation of feaR expression in order to optimize enzyme activities according to the nutritional environment .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>Upon addition of a FeaR effector , the feaB P1 promoter is activated by FeaR and CRP-cAMP and tynA is activated by FeaR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>In the presence of a FeaR effector , feaB is not expressed , most likely because CRP-cAMP is absent under these conditions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>FeaR expressed from pBAD24 activated the tynA promoter significantly above basal levels ( to 500 units ) in the absence of a co-activator and to high levels in the presence of tyramine .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>Thus , the magnitude of the repression exerted by NsrR on the feaB promoter is similar in both the presence and the absence of FeaR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=18658270" target="_blank">18658270</a>]<br></li>
<li>We showed that the FeaR CTD can bind to DNA in vitro and can activate the tynA promoter in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>In fulllength FeaR , the NTD appears to act to inhibit the CTD in the absence of the coactivator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>Interestingly , the CTD activated tynA better than full-length FeaR in the absence of the coactivator , and this pattern was reversed in the presence of the ligand , suggesting that the NTD might function as an inhibitor of the CTD in the absence of the coactivator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>The FeaR CTD can better activate the tynA promoter than full-length FeaR in the absence of the coactivator ; this pattern is reversed in the presence of coactivator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
				</div></ul><br>
			<label class="collapse_DOM" for="_2"><font size="5px">FeaR protein domains</font></label>
				<input id="_2" type="checkbox">
				<div class="DOM"><br><ul><li>Thus , activation by FeaR requires the NTD , as is the case for other AraC-family members .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>Within each 16-bp sequence , nucleotides within the TGNCA-N8-AAA motif make signiﬁcant contributions to FeaR binding , while some nucleotides outside the motif also make minor contributions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>This behavior is consistent with the presence of two FeaR binding sites in the tynA noncoding region .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>To address the importance of speciﬁc residues within the FeaR binding sites , we performed competition binding assays with unlabeled DNAs containing single-site substitutions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
				</div></ul><br>
			<label class="collapse_EVO" for="_3"><font size="5px">FeaR evolution</font></label>
				<input id="_3" type="checkbox">
				<div class="EVO"><br><ul><li>In this respect , FeaR is similar to other AraC family members ( 9 , 12 , 39 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>Thus , activation by FeaR requires the NTD , as is the case for other AraC family members .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
				</div></ul><br>
			<label class="collapse_RP" for="_4"><font size="5px">Processes regulated by FeaR</font></label>
				<input id="_4" type="checkbox">
				<div class="RP"><br><ul><li>Finely Tuned Regulation of the Aromatic Amine Degradation Pathway in Escherichia coli Ji Zeng , Stephen Spiro Department of Molecular and Cell Biology , The University of Texas at Dallas , Richardson , Texas , USA FeaR is an AraC family regulator that activates transcription of the tynA and feaB genes in Escherichia coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>FeaR controls expression of a pathway for the degradation of potentially toxic aromatic compounds .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>In conclusion , we have studied the regulation of the aromatic amine-degradation pathway of E. coli and found that the genes encoding the ﬁrst two enzymes of the pathway are subject to complex regulation involving FeaR and other proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
				</div></ul><br>
			<label class="collapse_SIT" for="_5"><font size="5px">FeaR binding site</font></label>
				<input id="_5" type="checkbox">
				<div class="SIT"><br><ul><li>Within each 16-bp sequence , nucleotides within the TGNCA-N8-AAA motif make signiﬁcant contributions to FeaR binding , while some nucleotides outside the motif also make minor contributions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>All eight of these substitutions fall with the TGNCA-N8-AAA element that is present in both fragments , and so the data are consistent with the proposal that this sequence is the FeaR binding site .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>Arrows indicate nucleotides that constitute the directly repeated TGNCA-N8-AAA , which is the proposed FeaR consensus binding site .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>To identify the FeaR binding site , tynA promoter regions and feaR-feaB intergenic regions from different bacteria were collected and used in a search for enriched sequence motifs using the MEME algorithm ( 38 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>The rhodamine-X ( ROX ) - labeled 31-nucle-otide ( nt ) site 1 and site 2 contain 21 nt of the ﬁrst and second repeats of the FeaR binding site , respectively , ﬂanked by 5 nt upstream and downstream of the full-length FeaR binding site .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>The binding sites for FeaR as deﬁned in this study are boxed .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>The predicted FeaR binding sites are underlined .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>The FeaR binding sites are highlighted by lines above the sequence , and the predicted CRP binding site is underlined .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>The 3 = end of the promoter-proximal FeaR binding site is 32 bp upstream of the tynA P1 and feaB P1 start sites ( Fig. 2 ) ; in other words , the spacing between these sequence elements and the downstream transcription start sites is precisely conserved .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>Similarly , the FeaR binding site is two direct repeats upstream of the 35 region of tynA and feaB .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
				</ul></div><br>
			<label class="collapse_TU" for="_6"><font size="5px">Transcription unit regulated by FeaR</font></label>
				<input id="_6" type="checkbox">
				<div class="TU"><br><ul><li>The identity of the ligand for FeaR has not been established ; it may not be PEA ( or tyramine ) , given that TynA is located in the periplasm and that its substrate is , therefore , presumably not transported into the cell .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=18658270" target="_blank">18658270</a>]<br></li>
<li>Among the induced or repressed genes ( Tables S6 and S7 marked with d ) , 13 genes exhibiting a distinctive change in expression [ galS , mglA , mglB , mglC , tnaA , tnaB , yedF and yeeF ( Table S6 ) , and ﬂiD , ﬂiS , glnG , tap and yjcB ( Table S7 ) ] , and two genes encoding regulator proteins ( FeaR and HcaR ) were selected for the further study ( Table 1 marked with a d ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=19919618" target="_blank">19919618</a>]<br></li>
<li>We show that the expression of feaR is regulated by carbon or nitrogen limitation and is not subject to autoregulation by the FeaR protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>Sequences encoding FeaR and the CTD were ligated into pBAD24 for expression from the arabinose-inducible araBAD promoter .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>In the presence of a FeaR effector , feaB is not expressed , most likely because CRP-cAMP is absent under these conditions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>Thus , the magnitude of the repression exerted by NsrR on the feaB promoter is similar in both the presence and the absence of FeaR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=18658270" target="_blank">18658270</a>]<br></li>
<li>On the other hand , tynA transcription is activated by FeaR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>FeaR is known to be required for the expression of tynA and feaB ( 7 , 8 ) , but its role and mechanism have not otherwise been characterized .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
<li>This increase in feaR expression is not sufﬁcient to activate expression of tynA and feaB unless a pathway inducer is also present ( although a nonphysiological increase in FeaR abundance may lead to induction of its targets in the absence of inducer [ see Fig .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24013633" target="_blank">24013633</a>]<br></li>
				</div></ul></div><br>
	</div>
</body>
</html>